Home > Financial Ratios > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
Price to Cash Earnings (PCE)

    Back to All Ratios
BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

BALAXI PHARMACEUTICALS Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   PCE(x) 13.09-1,872.7511.327.3013.65

What is the latest Price to Cash Earnings (PCE) ratio of BALAXI PHARMACEUTICALS ?

The latest Price to Cash Earnings (PCE) ratio of BALAXI PHARMACEUTICALS is 13.09 based on Mar2025 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202513.09
Mar2024-1,872.75
Mar202311.32
Mar20227.30
Mar202113.65

How is Price to Cash Earnings (PCE) of BALAXI PHARMACEUTICALS Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2025 13.09
Positive
Mar2024 -1872.75
Negative
Mar2023 11.32
55.07
Mar2022 7.3
-46.52
Mar2021 13.65 -

Other Financial Ratios of BALAXI PHARMACEUTICALS


Compare Price to Cash Earnings (PCE) ratio of peers of BALAXI PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS ₹127.1 Cr -5.7% -16.7% -64.7% Stock Analytics
ADANI ENTERPRISES ₹289,089.0 Cr 15.2% -1% 0.4% Stock Analytics
REDINGTON ₹20,892.9 Cr 0.3% -6.4% 36.7% Stock Analytics
MMTC ₹9,483.0 Cr 0.3% -5.4% -6.3% Stock Analytics
LLOYDS ENTERPRISES ₹9,466.2 Cr 10.7% -6.2% 23.3% Stock Analytics
HONASA CONSUMER ₹9,149.4 Cr 1.4% -6.3% 25.8% Stock Analytics


BALAXI PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS

-5.7%

-16.7%

-64.7%

SENSEX

1.3%

-2.5%

8.5%


You may also like the below Video Courses